Matthias Löhr
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matthias Löhr
Earlier roles on record: Board Member at PharmaCyte Biotech, Inc. (PMCB) until August 16, 2022. PharmaCyte Biotech, Inc. reported in an 8-K filed August 16, 2022 that Matthias Löhr resigned as Board member. PharmaCyte Biotech, Inc. reported in an 8-K filed August 16, 2022 that Matthias Löhr resigned as member of the Board, effective August 15, 2022.
“Each resigned from the Board as part of the Cooperation Agreement after determining that the Cooperation Agreement, including the composition of the new Board, was in the best interest of the Company moving forward.”
“effective August 15, 2022, each of Dr. Matthias Löhr, Dr. Tong, Mr. Liquard, Dr. Crabtree, and Mr. Trujillo resigned as members of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2022-03-31–2022-08-16
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.